Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Nursing Home & Skilled Nursing Facility Experts

Articles with lock require a subscription to GLG News | Request a free trial
November 18, 2008
Bullish on the Growth of this Therapeutic Sector
Analysis of: FDA: No link between bone drugs and heart problems | money.cnn.com
Author: GLG Expert Contributor
One more hurdle passed by what could be one of the fastest growing therapeutic treatment sectors over the next 20 years.
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
Analysis of: FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
Author: David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.
This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.
September 25, 2008
Narrowing the Category of "Carcinoma of Unknown Primary" Site-- still a ways to go
Analysis of: Raising the Profile of Cancer of Unknown Primary | jco.ascopubs.org
Author: GLG Expert Contributor
Diagnostic uncertainty in metastatic cancer as to the site of origin remains a problem in medicine today, albeit a slowly shrinking one. Immunohistochemistry using monoclonal antibodies from a host of makers will remain the mainstay in defining the site of origin, but it's proper use depends on accurate...
September 16, 2008
Updating Pricing on Brand to Generic Drugs are Timing and Inventory Issues for Payers and Providers
Analysis of: Medicare overpaid on drugs with new generics, report says | www.latimes.com
Author: GLG Expert Contributor
Payers in the private sector have historically tried to get providers to pay the generic price for branded multisource products using maximum allowable cost (MAC) terminology in their contracts as soon as the branded drugs have a generic source. This has caused problems for providers that still have...
Glen McDanielJuly 1, 2008
Boomers numbers and demands point to increased demand for medical real estate
Analysis of: Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals | www.bio-medicine.org
Author: Glen McDaniel, President and Chief Executive Officer, GM Global
Baby boomers are rapidly aging. According to Census Bureau by 2010 there will be 77 million people aged 55 and older; a number which will grow to a whopping 98 million by 2020. This aging population, living longer with chronic illnesses and more demanding of cafeteria-type service will drive the demand...
June 23, 2008
Issues with Ustekinumab
Analysis of: Positive news on J&J's ustekinumab diminished by safety concerns - analysts | www.tradingmarkets.com
Author: Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER
On Tuesday, the FDA's Dermatologic and Ophthalmic Drug Advisory Panel voted unanimously to approve the use of the injectable drug for the treatment of plaque psoriasis, a severe skin disease. As the FDA usually follows the recommendations of its advisory panels when reviewing new drugs for approval,...
May 27, 2008
You get what you pay for
Analysis of: Look to England's example for ways to solve America's health-care problem | www.sltrib.com
Author: GLG Expert Contributor
A single payer, national system does work, but may not necessarily be in the best interest of all parties.   Yes this type of system is 'free' to the users, but is funded through higher taxes than paid in the US.
May 15, 2008
Reverse Payments for PHRMA smell fishy
Analysis of: US trade agency wants to end deals delaying generics | www.reuters.com
Author: Bruce Goldberg, President, Pharmacy Express Services, Inc.
Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families.  My grandpa used to call this stuff...
February 11, 2008
Fosamax generic...
Analysis of: Teva wins FDA OK to sell generic Fosamax | www.reuters.com
Author: David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.
It is important to understand the generic implications when it comes to drug product olacement on the formulary.
February 11, 2008
Zyprexa safety
Analysis of: FDA Advisory Committee Supports Efficacy and Safety of Zyprexa | www.fiercebiotech.com
Author: David Zimmerman, President/Owner, Doctors of Pharmacy, Inc.
This article is informative because it draws conclusions about Zyprexa.

Page : 1 2 3 4 5 6 7 8 9 10 Next1 to 10 of 155

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-04T21:45:18.380